Unbiased AI-powered news
8 stories related to this topic, newest first.
realitytea.comPresident Trump signed an executive order last month directing faster research and increased federal funding for psychedelic drug therapies. Rep. Lou Correa (D-CA) said the measure could help veterans with PTSD or traumatic brain injuries as well as people facing other mental hea…
bbc.comVeterans who received ibogaine in a Tijuana clinic reported reduced disability from PTSD, depression and anxiety after one session. Researchers linked the intensity of immersive experiences to symptom improvements one month later. President Donald Trump signed an executive order…
realitytea.comPresident Trump signed an executive order in April that accelerates research and increases funding for psychedelic drug therapies. A California congressman leading a bipartisan effort to advance the therapies discussed the initiative on CBS News. The discussion emphasized support…
NewsweekThe U.S. Department of Veterans Affairs has committed more than $1 billion of its record $4.8 billion facilities budget for 2026, part of the largest annual investment in the department's history. The latest $596 million in approvals will fund repairs to aging hospital systems, p…
citizen.co.zaBob Caesar, a former Royal Australian Air Force corporal, developed a rare terminal lung disease linked to trichloroethylene exposure during the 1970s. The federal government initially contested his negligence claim before reaching a settlement the day before trial. The case is t…
ibtimes.co.ukScientists have indicated that MDMA may help treat trauma in war veterans. Gilly Norton, chief executive of Supporting Wounded Veterans, stated that MDMA began as a therapeutic substance before being adopted in recreational settings. The substance's potential medical applications…
Substrate placeholder — needs reviewThe U.S. administration is preparing an executive order to support federal research on ibogaine, a psychedelic drug used abroad to treat PTSD and other conditions. Ibogaine remains illegal in the U.S. and classified as a Schedule I substance.
Substrate placeholder — needs reviewEdna Foa, an Israeli American psychologist, died on March 24, 2026, at a hospital in Philadelphia from complications of pneumonia. She developed prolonged exposure therapy in the 1980s, a treatment involving structured sessions to confront traumatic memories. The Department of Ve…